A very exciting week for patients with hepatitis C viral (HCV) infections of the genotypes 3 and 4
July 31, 2015 – This week, just in time for World Hepatitis Day on July 28, the American Food and Drug Administration (FDA) approved Daclatasvir (Daklinza) for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections. In addition, the …